CARBIOS confirms PET biorecycling plant with revised timeline
CARBIOS has published its half-year 2025 results, reaffirming its objective to build a PET biorecycling plant in Longlaville, France, with an updated timeline. As of 30 June 2025, the company reported a solid cash position of €72 million, providing a financial horizon of more than twelve months.
Progress on the Longlaville project
Construction of the Longlaville plant is expected to resume before the end of 2025, subject to securing the necessary funding. Commissioning is now planned for the second half of 2027. Public funding totalling €42.5 million – including a €30 million grant from the French Environment and Energy Management Agency (ADEME) and €12.5 million in regional support – has been confirmed but not yet disbursed. CARBIOS is also in discussions with private investors, whose participation depends on the pre-sale of a significant portion of the plant’s future capacity.
Regulatory developments in France
A decree published in September 2025 under France’s Environmental Code introduces financial incentives for the use of recycled materials. It grants a €1,000 per tonne bonus for biorecycled plastics used in sensitive-contact packaging, such as food applications. This measure strengthens the competitiveness of CARBIOS’ technology, enabling the production of high-quality recycled PET (rPET) with properties equivalent to virgin PET, while processing complex waste streams that are currently not recycled.
Financial performance and outlook
For the first half of 2025, CARBIOS reported an operating loss of €17.6 million, an improvement from €20 million in the same period of 2024, reflecting the company’s cost reduction efforts. The net loss for the period stood at €23.5 million.
With reduced operating expenses and a strong cash position, CARBIOS continues to engage with public and private partners to secure the necessary funding for the Longlaville project. The company remains focused on advancing industrial-scale PET biorecycling and the commercialisation of its technology licences.